EP Wealth Advisors’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.3M Buy
23,865
+2,041
+9% +$99.4K 0.01% 684
2026
Q1
$936K Sell
21,824
-1,055
-5% -$45.4K ﹤0.01% 656
2025
Q4
$1M Buy
+22,879
New +$946K 0.01% 623
2025
Q2
$853K Sell
19,354
-410
-2% -$16.4K 0.01% 606
2025
Q1
$730K Buy
19,764
+6,570
+50% +$234K 0.01% 581
2024
Q4
$439K Buy
13,194
+1,390
+12% +$45.1K ﹤0.01% 734
2024
Q3
$306K Buy
+11,804
New +$293K ﹤0.01% 851

Other funds holding EXEL

EP Wealth Advisors's EXEL Position: Q2 2026 in Review

EP Wealth Advisors increased its Exelixis (EXEL) stake by 9.4% in Q2 2026, buying an estimated $99.4K and bringing the position to 23,865 shares worth $1.3M. The position accounts for 0.01% of the portfolio, ranked #684.

EP Wealth Advisors first reported a position in EXEL in Q3 2024 and has held it in 7 quarters since. 758 funds tracked by Wall St. Rank hold EXEL as of Q2 2026.

  • EP Wealth Advisors held 23,865 shares of Exelixis worth $1.3M as of Q2 2026.
  • EP Wealth Advisors bought 2,041 Exelixis shares in Q2 2026, an estimated $99.4K.
  • Exelixis made up 0.01% of EP Wealth Advisors's portfolio in Q2 2026, its #684 holding.
  • EP Wealth Advisors first reported a position in Exelixis in Q3 2024 and has held it in 7 quarters since.
  • 758 funds tracked by Wall St. Rank held Exelixis as of Q2 2026.

Based on EP Wealth Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.